Physician profile
Dmitry Sandler
NPI 1588753040
$10,809.07
in general payments reported to CMS, 2019-2025
38 companies · $1,762 in 2025
The $1,762 reported for 2025 was more than what 93% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,806 · 2020: $638 · 2021: $1,479 · 2022: $1,192 · 2023: $1,073 · 2024: $859 · 2025: $1,762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,898 · Travel and Lodging: $797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,897.64 |
| Travel and Lodging | $796.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,464.58 | 2019-2023 | Stravix, Grafix Pl |
| Paragon 28, INC. | $1,424.49 | 2020-2022 | |
| Treace Medical Concepts, INC. | $1,284.56 | 2022-2025 | |
| Orthofix Medical, INC. | $1,211.74 | 2019 | |
| Organogenesis INC. | $787.60 | 2019-2025 | Puraply Wound Matrix, Via Matrix |
| Ossio INC | $525.81 | 2023-2024 | |
| Abbvie INC. | $484.58 | 2022-2024 | Dalvance, Avycaz, Teflaro |
| Stryker Corporation | $440.72 | 2019 | |
| Osiris Therapeutics INC. | $398.65 | 2019 | |
| Linvatec Corporation | $296.80 | 2023-2025 | Biobrace 23mm, In2bones USA, Colink 2 |
| Bioventus LLC | $266.36 | 2022-2023 | Exogen Ultrasound Bone Healing System |
| Wright Medical Technology, INC. | $248.10 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $155.93 | 2022-2023 | Seglentis |
| Depuy Synthes Sales INC. | $148.81 | 2019-2020 | |
| Biotissue Holdings INC. | $147.52 | 2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bone Support INC. | $140.93 | 2024 | Cerament G, Ceramentbone Void Filler |
| Biocomposites INC | $135.81 | 2023 | Stimulan |
| Zimmer Biomet Holdings, INC. | $134.76 | 2019-2020 | |
| Restor3d, INC. | $129.60 | 2023 | |
| Medtronic, INC. | $126.73 | 2024 | Venaseal |
| Astrazeneca Pharmaceuticals Lp | $125.00 | 2021 | |
| Heron Therapeutics, INC. | $121.84 | 2025 | Zynrelef, Aponvie |
| Nevro Corp. | $120.82 | 2022 | |
| Nalu Medical, INC. | $101.98 | 2022 | |
| Solventum Corporation | $82.04 | 2025 | Activ.A.C., Promogran, 3m Cavilon |
| Novastep INC. | $48.54 | 2022 | |
| Aroa Biosurgery Incorporated | $32.24 | 2024 | |
| Checkpoint Surgical, INC | $26.14 | 2022 | |
| Highridge Medical LLC | $25.42 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Ebi, LLC | $25.42 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Acell, INC. | $25.41 | 2019 | |
| Kerecis Limited | $22.90 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Merck Sharp & Dohme LLC | $18.50 | 2019 | |
| Abbott Laboratories | $16.99 | 2024 | Armada |
| Embody, INC. | $16.61 | 2021 | |
| Zimvie INC. | $15.46 | 2022 | |
| Acera Surgical, INC. | $15.38 | 2022 | |
| Mimedx Group, INC. | $14.30 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dmitry Sandler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.